These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 8122618)

  • 1. Hematocrit and the risk of cardiovascular disease--the Framingham study: a 34-year follow-up.
    Gagnon DR; Zhang TJ; Brand FN; Kannel WB
    Am Heart J; 1994 Mar; 127(3):674-82. PubMed ID: 8122618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematocrit and the risk of coronary heart disease mortality.
    Brown DW; Giles WH; Croft JB
    Am Heart J; 2001 Oct; 142(4):657-63. PubMed ID: 11579356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red blood cell count in short-term prediction of cardiovascular disease incidence in the Gubbio population study.
    Puddu PE; Lanti M; Menotti A; Mancini M; Zanchetti A; Cirillo M; Angeletti M;
    Acta Cardiol; 2002 Jun; 57(3):177-85. PubMed ID: 12088175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematocrit and risk of coronary heart disease: the Puerto Rico Health Program.
    Sorlie PD; Garcia-Palmieri MR; Costas R; Havlik RJ
    Am Heart J; 1981 Apr; 101(4):456-61. PubMed ID: 7211675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in cardiovascular disease incidence and survival in the elderly.
    Haan MN; Selby JV; Rice DP; Quesenberry CP; Schofield KA; Liu J; Fireman BH
    Ann Epidemiol; 1996 Jul; 6(4):348-56. PubMed ID: 8876846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematocrit and the risk of cardiovascular disease in a Japanese community: The Hisayama Study.
    Gotoh S; Hata J; Ninomiya T; Hirakawa Y; Nagata M; Mukai N; Fukuhara M; Ikeda F; Ago T; Kitazono T; Kiyohara Y
    Atherosclerosis; 2015 Sep; 242(1):199-204. PubMed ID: 26204496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous sex hormones and cardiovascular disease incidence in men.
    Arnlöv J; Pencina MJ; Amin S; Nam BH; Benjamin EJ; Murabito JM; Wang TJ; Knapp PE; D'Agostino RB; Bhasin S; Vasan RS
    Ann Intern Med; 2006 Aug; 145(3):176-84. PubMed ID: 16880459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular disease incidence and mortality in older men with diabetes and in men with coronary heart disease.
    Wannamethee SG; Shaper AG; Lennon L
    Heart; 2004 Dec; 90(12):1398-403. PubMed ID: 15547012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart rate recovery after treadmill exercise testing and risk of cardiovascular disease events (The Framingham Heart Study).
    Morshedi-Meibodi A; Larson MG; Levy D; O'Donnell CJ; Vasan RS
    Am J Cardiol; 2002 Oct; 90(8):848-52. PubMed ID: 12372572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary disease and stroke in patients with large-vessel peripheral arterial disease.
    Criqui MH; Langer RD; Fronek A; Feigelson HS
    Drugs; 1991; 42 Suppl 5():16-21. PubMed ID: 1726213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes and cardiovascular disease. The Framingham study.
    Kannel WB; McGee DL
    JAMA; 1979 May; 241(19):2035-8. PubMed ID: 430798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Framingham Study: historical insight on the impact of cardiovascular risk factors in men versus women.
    Kannel WB
    J Gend Specif Med; 2002; 5(2):27-37. PubMed ID: 11974672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperinsulinemia and cardiovascular disease in elderly men: the Honolulu Heart Program.
    Burchfiel CM; Sharp DS; Curb JD; Rodriguez BL; Abbott RD; Arakaki R; Yano K
    Arterioscler Thromb Vasc Biol; 1998 Mar; 18(3):450-7. PubMed ID: 9514414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of gamma-glutamyltransferase in cardiovascular risk prediction in men without diagnosed cardiovascular disease or diabetes.
    Wannamethee SG; Lennon L; Shaper AG
    Atherosclerosis; 2008 Nov; 201(1):168-75. PubMed ID: 18378241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic interactions between cardiovascular risk factors.
    Vishram JK
    Dan Med J; 2014 Jul; 61(7):B4892. PubMed ID: 25123126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study.
    Hubert HB; Feinleib M; McNamara PM; Castelli WP
    Circulation; 1983 May; 67(5):968-77. PubMed ID: 6219830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of Framingham cardiovascular disease (CVD) predictions in the Rotterdam Study taking into account competing risks and disentangling CVD into coronary heart disease (CHD) and stroke.
    van Kempen BJ; Ferket BS; Kavousi M; Leening MJ; Steyerberg EW; Ikram MA; Witteman JC; Hofman A; Franco OH; Hunink MG
    Int J Cardiol; 2014 Feb; 171(3):413-8. PubMed ID: 24438922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Favorable cardiovascular risk profile in young women and long-term risk of cardiovascular and all-cause mortality.
    Daviglus ML; Stamler J; Pirzada A; Yan LL; Garside DB; Liu K; Wang R; Dyer AR; Lloyd-Jones DM; Greenland P
    JAMA; 2004 Oct; 292(13):1588-92. PubMed ID: 15467061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematocrit and the risk of coronary heart disease mortality in the TAMRISK study, a 28-year follow-up.
    Kunnas T; Solakivi T; Huuskonen K; Kalela A; Renko J; Nikkari ST
    Prev Med; 2009 Aug; 49(1):45-7. PubMed ID: 19409924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of smoking status on 9.3 years incidence of cardiovascular and all-cause mortality among Iranian men.
    Ehteshami-Afshar S; Momenan A; Hajshekholeslami F; Azizi F; Hadaegh F
    Ann Hum Biol; 2014; 41(3):249-54. PubMed ID: 24215537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.